Colorado aspmn avatar
ASPMN Colorado Chapter

CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016

Posted about 3 years ago by Betsy Woolf

1/30/2016  (Update from Chris Pasero) BOARD RECOMMENDS TWEAKS TO CDC'S OPIOID GUIDELINE - The board of scientific counselors to the agency's National Center for Injury Prevention and Control have signed off on a workgroup's report suggesting relatively minor changes to CDC's draft opioid guidelines, Pro's Brett Norman reports. But neither the workgroup report nor the board found consensus on a CDC recommendation for how long opioids should be prescribed for acute, non-traumatic pain, leaving the resolution of that controversial standard to the agency alone. It was the last step in the public vetting of draft guideline. Now the CDC settles in with the board's input and more than 4,000 public comments to finalize the guideline and get it cleared for release. The workgroup report:

1/18/2016   Update:  Although the public comment period is past, the Resources Section houses a link to the proposed guidelines and the ASPMN response.  


The CDC proposed opioid prescribing guidelines were reopened for public comment through January 14th. 

YOUR comments are a valuable part of the shared forum among all who are invested in caring for people with persistent pain.

To post your comment to the CDC:

Go to the Federal eRulemaking Portal:!documentDetail;D=CDC-2015-0112-0001

Follow the instructions for submitting comments (NOTE: "Comment Now" button in upper right corner of screen).

National Center for Injury Prevention and Control, Centers for Disease Control and Prevention
Attn: Docket CDC-2015-0112
4770 Buford Highway N.E., Mailstop F-63,
Atlanta, GA, 30341

All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to, including any personal information provided. For access to the docket to read background documents or comments received, go to


No comments yet.

Only our followers can comment on this announcement.